She is a Postdoctoral Fellow at Houston Methodist Research Institute (Houston, TX, USA) in the Center for Musculoskeletal Regeneration and the Department of Orthopedics & Sports Medicine. Her research combines mesenchymal stromal/stem cell (MSC) therapy with engineered biomimetic biomaterials that harness immunomodulation to drive cartilage and bone tissue repair. A key innovation of her current work is the investigation of musculoskeletal, peri-articular MSC sources as less invasive alternative to bone marrow. By identifying and validating locally harvested MSC populations, this approach is enabling clinically scalable MSC-based cell therapies and driving clinical translation through an ongoing Phase I clinical trial for ACL repair. She earned an M.S. in Biomedical Engineering (2018) and a Ph.D. in Bioengineering and Medical-Surgical Sciences (2022) at Politecnico di Torino (Turin, ITA). During her Ph.D., she contributed to major European-funded research programs (ERC-BOOST and H2020-GIOTTO), developing advanced drug-delivery systems for growth factors and integrating them with natural polymers to generate 3D-printed, collagen-based scaffolds for bone regeneration. She also designed and implemented a clinically driven injectable, bioresorbable composite bone cement with radiopaque and bioactive features for the treatment of osteoporotic vertebral fractures.